Your browser doesn't support javascript.
loading
Chitosan Microbeads Produced by One-Step Scalable Stirred Emulsification: A Promising Process for Cell Therapy Applications.
Alinejad, Yasaman; Bitar, Christina M E; Martinez Villegas, Karina; Perignon, Sarah; Hoesli, Corinne A; Lerouge, Sophie.
Afiliação
  • Alinejad Y; Laboratory of Endovascular Biomaterials (LBeV), Centre de recherche du CHUM (CRCHUM), 900 Saint-Denis Street, Montreal, Quebec H2X 0A9, Canada.
  • Bitar CME; Department of Mechanical Engineering, École de technologie supérieure (ETS), 1100 Notre-Dame West, Montreal, Quebec H3C 1K3, Canada.
  • Martinez Villegas K; Department of Chemical Engineering, McGill University, Wong Building, 3610 University Street #3060, Montreal, Quebec H3A 0C5, Canada.
  • Perignon S; Laboratory of Endovascular Biomaterials (LBeV), Centre de recherche du CHUM (CRCHUM), 900 Saint-Denis Street, Montreal, Quebec H2X 0A9, Canada.
  • Hoesli CA; Department of Mechanical Engineering, École de technologie supérieure (ETS), 1100 Notre-Dame West, Montreal, Quebec H3C 1K3, Canada.
  • Lerouge S; Laboratory of Endovascular Biomaterials (LBeV), Centre de recherche du CHUM (CRCHUM), 900 Saint-Denis Street, Montreal, Quebec H2X 0A9, Canada.
ACS Biomater Sci Eng ; 6(1): 288-297, 2020 01 13.
Article em En | MEDLINE | ID: mdl-33463194
ABSTRACT
Cell microencapsulation is a promising approach to improve cell therapy outcomes by protecting injected cells from rapid dispersion and allowing bidirectional diffusion of nutrients, oxygen, and waste that promote cell survival in the target tissues. Here, we describe a simple and scalable emulsification method to encapsulate animal cells in chitosan microbeads using thermosensitive gel formulations without any chemical modification and cross-linker. The process consists of a water-in-oil emulsion where the aqueous phase droplets contain cells (L929 fibroblasts or human mesenchymal stromal cells), chitosan acidic solution and gelling agents (sodium hydrogen carbonate and phosphate buffer or beta-glycerophosphate). The oil temperature is maintained at 37 °C, allowing rapid physical gelation of the microbeads. Alginate beads prepared with the same method were used as a control. Microbeads with a diameter of 300-450 µm were successfully produced. Chitosan and alginate (2% w/v) microbeads presented similar rigidity in compression, but chitosan microbeads endured >80% strain without rupture, while alginate microbeads presented fragile breakage at <50% strain. High cell viability and metabolic activity were observed after up to 7 days in culture for encapsulated cells. Mesenchymal stromal cells encapsulated in chitosan microbeads released higher amounts of the vascular endothelial growth factor after 24 h compared to the cells encapsulated in manually cast macrogels. Moreover, microbeads were injectable through 23G needles without significant deformation or rupture. The emulsion-generated chitosan microbeads are a promising delivery vehicle for therapeutic cells because of their cytocompatibility, biodegradation, mechanical strength, and injectability. Clinical-scale encapsulation of therapeutic cells such as mesenchymal stromal cells in chitosan microbeads can readily be achieved using this simple and scalable emulsion-based process.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quitosana / Terapia Baseada em Transplante de Células e Tecidos / Microesferas Limite: Animals / Humans Idioma: En Revista: ACS Biomater Sci Eng Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quitosana / Terapia Baseada em Transplante de Células e Tecidos / Microesferas Limite: Animals / Humans Idioma: En Revista: ACS Biomater Sci Eng Ano de publicação: 2020 Tipo de documento: Article